Orafaie A, Shahabi F, Mehri A, Ansari M, Kasraeifar S, Ghiyasi M
Cancer Med. 2024; 13(10):e7225.
PMID: 38778698
PMC: 11112298.
DOI: 10.1002/cam4.7225.
Urs A, Augustine J, Khurana N, Uniyal A, Passey J, Meher R
J Oral Maxillofac Pathol. 2023; 26(4):596.
PMID: 37082044
PMC: 10112119.
DOI: 10.4103/jomfp.jomfp_49_21.
Ishida H, Kasajima A, Yamauchi T, Akaishi R, Ueki S, Taniyama Y
Histol Histopathol. 2022; 38(2):155-163.
PMID: 35861388
DOI: 10.14670/HH-18-497.
Li B, Xiong F, Yi S, Wang S
Technol Cancer Res Treat. 2022; 21:15330338211070140.
PMID: 35025614
PMC: 8785352.
DOI: 10.1177/15330338211070140.
Kuru Pekcan M, Ozgu-Erdinc A, Yilmaz N, Tokmak A, Engin-Ustun Y
J Hum Reprod Sci. 2021; 14(1):11-15.
PMID: 34083986
PMC: 8057155.
DOI: 10.4103/jhrs.jhrs_216_20.
Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study.
Hu C, Yeh C, Chen J, Tsai C, Wang S, Cheng C
Oncol Lett. 2020; 20(3):2131-2142.
PMID: 32782530
PMC: 7400021.
DOI: 10.3892/ol.2020.11756.
p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection.
Ishida H, Kasajima A, Fujishima F, Akaishi R, Ueki S, Yamazaki Y
Virchows Arch. 2020; 478(2):219-229.
PMID: 32556556
PMC: 7969492.
DOI: 10.1007/s00428-020-02865-x.
Low Albumin to Fibrinogen Ratio Predicts Poor Overall Survival in Esophageal Small Cell Carcinoma Patients: A Retrospective Study.
Wang Y, Li J, Chang S, Zhou K, Che G
Cancer Manag Res. 2020; 12:2675-2683.
PMID: 32368146
PMC: 7183346.
DOI: 10.2147/CMAR.S250293.
Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer.
Lu Y, Xin D, Wang F
Onco Targets Ther. 2019; 12:7791-7799.
PMID: 31571929
PMC: 6759789.
DOI: 10.2147/OTT.S223419.
Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer Patients with Low CA125 Concentration.
Zhang H, Huo Q, Huang L, Cheng Y, Liu Y, Bao H
Biomed Res Int. 2019; 2019:8107906.
PMID: 31341906
PMC: 6614957.
DOI: 10.1155/2019/8107906.
Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study.
Yang Z, Wang F, Liu S, Guan W
Sci Rep. 2019; 9(1):10033.
PMID: 31296939
PMC: 6624285.
DOI: 10.1038/s41598-019-46520-1.
A comparative analysis of clinicopathological factors between esophageal small cell and basaloid squamous cell carcinoma.
Ishida H, Kasajima A, Onodera Y, Konno T, Maruyama S, Okamoto H
Medicine (Baltimore). 2019; 98(8):e14363.
PMID: 30813135
PMC: 6408094.
DOI: 10.1097/MD.0000000000014363.
Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer.
Stojkovic Lalosevic M, Pavlovic Markovic A, Stankovic S, Stojkovic M, Dimitrijevic I, Radoman Vujacic I
Dis Markers. 2019; 2019:6036979.
PMID: 30800188
PMC: 6360046.
DOI: 10.1155/2019/6036979.
Evaluation of neutrophil-to-lymphocyte ratio and calcitonin concentration for predicting lymph node metastasis and distant metastasis in patients with medullary thyroid cancer.
Xu N, Jian Y, Wang Y, Tian W
Mol Clin Oncol. 2018; 9(6):629-634.
PMID: 30546892
PMC: 6256259.
DOI: 10.3892/mco.2018.1727.
Prognostic and clinicopathological significance of platelet to lymphocyte ratio in esophageal cancer: a meta-analysis.
Deng J, Zhang P, Sun Y, Peng P, Huang Y
J Thorac Dis. 2018; 10(3):1522-1531.
PMID: 29707302
PMC: 5906230.
DOI: 10.21037/jtd.2018.02.58.
Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection.
Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V
J Gastrointest Surg. 2018; 22(9):1611-1618.
PMID: 29687424
DOI: 10.1007/s11605-018-3781-2.
Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis.
Zhao Q, Zhang X, Zhang H, Duan G
Oncotarget. 2018; 8(67):112085-112093.
PMID: 29340113
PMC: 5762381.
DOI: 10.18632/oncotarget.22557.
Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
Yang J, Guo X, Wang M, Ma X, Ye X, Lin P
Sci Rep. 2017; 7(1):17166.
PMID: 29215037
PMC: 5719445.
DOI: 10.1038/s41598-017-17130-6.
The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.
Dolan R, Lim J, McSorley S, Horgan P, McMillan D
Sci Rep. 2017; 7(1):16717.
PMID: 29196718
PMC: 5711862.
DOI: 10.1038/s41598-017-16955-5.
The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis.
Zhang J, Zhang H, Li J, Shao X, Zhang C
Oncotarget. 2017; 8(40):68837-68846.
PMID: 28978160
PMC: 5620300.
DOI: 10.18632/oncotarget.18575.